Open original FDA record ↗Recall record
- FDA identifier
- Z-0865-2024
- Company in FDA record
- GE HEALTHCARE AUSTRIA GMBH & CO
- FDA classification date
- Jan 30, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
GE HealthCare has become aware of an issue with certain IC9-RS ultrasound probes (see Affected Products List) that can result in a double image artifact creating a ghost image with realistic features. An unrecognized artifact may lead to misdiagnosis.
Source facts
- Action
- GE Healthcare issued an URGENT MEDICAL DEVICE CORRECTION notice to its consignees on 12/22/2023 via letter delivered using traceable means. The notice explained the issue with the device, safety issue, and requested the following actions be taken: 1. Ensure all potential users in your facility are made aware of this correction notification and the recommended actions. 2. You can continue to use your ultrasound system with all other probes. 3. Upon receipt of the letter, verify if your IC9-RS probe is functioning correctly prior to use by performing the Double Image artifact test provided in the letter. (Testing must be repeated monthly) 4. If a double image artifact is seen, do not use the probe and contact a GE HealthCare representative to get a replacement probe. 5. Complete and return the attached acknowledgement form to Recall.79072@ge.com. Please retain this document for your records.
- Initiated
- 2023-12-22
- Root cause
- Device Design
- Distribution
- worldwide
- Recall number
- Z-0865-2024
- Recall status
- Open, Classified
- CDRH record ID
- 205320
- FDA classified
- 2024-01-30
- Recall event number
- 93727